1Y Close · As of Aug 26, 2026
T&R Biofab operates in the Pharmaceuticals sector.
Legal name: T&R Biofab Co., Ltd
In fiscal year 2025, T&R Biofab (246710) reported revenue of 27.0 billion KRW, up 453.3% from 4.9 billion KRW a year earlier.
Operating profit was -9.1 billion KRW and net income was -34.9 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 118.2 billion KRW, with a P/B of 5.12.
These figures can be verified in the DART filing (receipt no. 20260318001580).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 27.0B | -9.1B | -34.9B |
| 2024 | 4.9B | -13.3B | -7.7B |
| 2023 | 5.2B | -12.7B | -13.4B |
Recent Filings
Large Shareholding Report (General)
Officer/Major Shareholder Ownership Report
Officer/Major Shareholder Ownership Report
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-19 | Large Shareholding Report (General) |
| 2026-08-04 | Officer/Major Shareholder Ownership Report |
| 2026-08-04 | Officer/Major Shareholder Ownership Report |
| 2026-08-04 | Officer/Major Shareholder Ownership Report |
| 2026-08-04 | Large Shareholding Report (General) |